摘要
目的探讨糖尿病肾病合并高血压患者降压药物的合理选择。方法根据患者的全程药学监护,分析1例糖尿病肾病合并高血压患者的药物使用情况。结果血管紧张素受体阻断剂(ARB)+钙通道阻滞剂(CCB)联合用于糖尿病肾病合并高血压,不仅很好地控制了血压,而且延缓了肾病的发展。结论对于糖尿病肾病合并高血压患者的治疗,应首选肾素-血管紧张素-醛固酮系统(RAAS)阻断剂、血管紧张素转换酶抑制剂(ACEI)/ARB,在此基础上可联合CCB或利尿剂,三联用药疗效也较好。
Objective Discussion on reasonable selection of early diabetic nephropathy with hypertension medication of antihypertensive drugs. Methods According to the whole pharmaceutical care for patients, analysis of a case of antihypertensive drugs in patients with diabetic nephropathy usage. Results The combination of ARB+CCB not only for diabetic nephropathy patients with hypertension can develop good blood pressure control can delay renal disease. Conclusion In the treatment of diabetic nephropathy patients with hypertension, should be the preferred RAS blocker ACEIVARB, on this basis can be combined with CCB or diuretics, or triple therapy.
出处
《基层医学论坛》
2013年第14期1772-1774,共3页
The Medical Forum
关键词
糖尿病肾病
高血压
降压药物
临床药师
Diabetic nephmpathy Hypertension Drug therapy Clinical pharmacist